Qinglan Li
-
- MicroRNA in disease regulation 3
-
- Epigenetics and DNA Methylation 9
- Genomics and Chromatin Dynamics 6
- RNA modifications and cancer 6
- Ubiquitin and proteasome pathways 4
- Advanced biosensing and bioanalysis techniques 4
- RNA Research and Splicing 4
-
- Biosensors and Analytical Detection 5
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Qinglan Li
35 papers receiving 613 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 139
- Molecular Biology 442
- Immunology 59
- Oncology 75
- Pulmonary and Respiratory Medicine 55
Countries citing papers authored by Qinglan Li
This map shows the geographic impact of Qinglan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglan Li more than expected).
Fields of papers citing papers by Qinglan Li
This network shows the impact of papers produced by Qinglan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglan Li. The network helps show where Qinglan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qinglan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 20 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 13 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 12 | |
| 11 | 2022 | 46 | |
| 12 | 2022 | 54 | |
| 13 | 2021 | 26 | |
| 14 | 2021 | 13 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 63 | |
| 17 | 2019 | 6 | |
| 18 | 2019 | 47 | |
| 19 | 2018 | 4 | |
| 20 | 2016 | 21 |
About Qinglan Li
Qinglan Li is a scholar working on Cancer Research, Physiology and Molecular Biology, having authored 35 papers that have together received 619 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), Genomics and Chromatin Dynamics (6 papers), RNA modifications and cancer (6 papers), Biosensors and Analytical Detection (5 papers), Ubiquitin and proteasome pathways (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA Research and Splicing (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (139 citations), Molecular Biology (442 citations) and Immunology (59 citations). Qinglan Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Min Wu, Lianyun Li, Lingao Ju, Chuan Gao, Mei Ye, Yingying Zhong, Suqing Zhao, Xin Ting Zheng, Xian Jun Loh and Pin‐Ji Lei. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.